HealthTech 2026: Innovation, Prevention & the Future of Health
Join us for HealthTech 2026 as we explore Greater Manchester's strengths in health data, digital innovation, AI, integrated care and HealthTech adoption, while showcasing the people, organisations and technologies improving patient outcomes and supporting prevention.
Agenda HERE!
Throughout the conference, we'll examine the shift towards neighbourhood health and new models of care, focusing on prevention, community-based support and digital solutions that help people stay healthier for longer.
The event will conclude with an interactive session - Let’s collaborate?! 2036 FUTURE FOCUS – What could Greater Manchester HealthTech look like in ten years? Where we will challenge the audience to imagine GM’s HealthTech ecosystem in 2036.
Whether you're a HealthTech business, investor, healthcare professional, technology company, public sector leader or professional services adviser, join us to connect, learn and discover what's next for healthcare innovation.
Limited tickets are available free to NHS staff, please email [email protected].
A fantastic way to showcase your brand. As a sponsor of the Health Tech Conference, you will have the opportunity to raise your profile and promote your brand to the industry’s most influential figures. For further information, contact [email protected].
About the Speakers:
Adam Dustagheer is CEO and Founder of Datnexa, an AI and digital transformation partner helping public-service organisations turn data and technology into practical, measurable outcomes. With more than 20 years’ experience across government, healthcare, regulation and the third sector, he specialises in responsible, people-centred AI adoption. Adam’s work focuses on applying AI to real-world challenges – supporting prevention, improving services and helping organisations build the confidence, capability and governance needed to scale innovation safely.
Dr Anthony Wilson is a consultant of anesthesia and critical care medicine at Manchester University NHS Foundation Trust (MFT). He is the Chief Medical Information Officer (Research and Innovation) at MFT where he champions the use of health data and the adoption of innovative technology to improve patient care and outcomes. His personal research interests focus on the use of wearable vital signs sensors in hospitals and he is the co-lead of MFT’s wearables laboratory.
Professor Amy Harwood is a registered AHCS Clinical Exercise Physiologist whose research and knowledge exchange activities focus on the development, evaluation and implementation of exercise and other therapeutic interventions for clinical populations. Her work has a particular emphasis on improving outcomes for people living with peripheral artery disease, with interests spanning rehabilitation, physical activity promotion, vascular health and the translation of evidence into clinical practice. Through collaborative research with healthcare providers, industry and patient groups, she is committed to advancing patient-centred approaches that improve health, function and quality of life.
Amy Wild is Founder of Silvia Health, a structured triage support platform for menopause care built around NICE NG23. Silvia helps GP practices, private clinics and pharmacies run consistent menopause services, giving clinicians the full picture before the consultation and following each woman over time. Amy started Silvia after her own experience of poor perimenopause care. She brings a background in commercial leadership, including CCO at Northcoders through its AIM listing and co-founding Basecamp. Her focus is making good menopause care consistent and easy to access, wherever a woman asks for help.
Azra Zia is the Health Inclusion and Community Engagement Manager at Prevent Breast Cancer, working to improve breast health equity for women from ethnically diverse and socially disadvantaged communities across Greater Manchester. Working with NHS partners and trusted grassroots organisations, she develops culturally relevant approaches to raising awareness of breast cancer prevention and early diagnosis. Azra believes communities are not “hard to reach” but often under-served by traditional health messaging. She is passionate about ensuring women have the information and support needed to make informed decisions about their breast health and welcomes neighbourhood solutions that improve access and build trust.
Dace Dimza-Jones is the Life Sciences Sector Development Lead at Greater Manchester Business Growth Hub, where she works across industry, the NHS, academia, investors, and government to strengthen the region’s Life Sciences ecosystem and support business growth, innovation, and collaboration. With over 13 years of NHS operational and clinical research experience across more than 30 therapeutic areas, she brings extensive expertise in clinical trials, healthcare innovation, research delivery, and NHS adoption. Dace has worked closely with the NIHR, NHS organisations, universities, Life Sciences companies, and private venture capital investors to accelerate commercialisation, foster strategic partnerships, and support the growth of high-potential health innovation businesses. She also serves as a Dealmaker for the UK Government’s Global Entrepreneur Programme, supporting international founders to establish and scale Life Sciences ventures in the UK.
Professor Deborah James (BSc, MA, PhD, SLT) is Professor of Educational Psychology and Deputy Pro-Vice-Chancellor for Health and Social Care at Manchester Metropolitan University and Special Advisor for Health and Social Care to the Institute for Children’s Futures. She leads the health and social care strategy at Manchester Met and works with key partners to deliver Manchester Met’s mission to reduce health inequity for families and communities.
Dr John Littler is Clinical Lead at Neko Health Manchester, where he leads a team of more than 40 doctors delivering preventive care across two clinics. Neko Health combines proprietary technology with doctor-led assessments. The aim is to find health risks earlier, rather than waiting for illness to appear.
John is a practising GP. He was previously an NHS GP partner at a multi-site practice in Manchester and the founding Clinical Director of a primary care network serving more than 50,000 patients. He is interested in how data from repeat assessments and wearables can guide individual care, help people make lasting changes to their health behaviours and reveal patterns across populations.
Kevin is a Partner in Browne Jacobson’s life sciences team, specialising in commercialisation and complex commercial contracting for life sciences, medtech and healthcare companies. He advises clients ranging from university spin-outs and venture-backed start-ups to multinational organisations and PLCs on the commercial agreements that underpin innovation, investment and international growth.
Kevin’s approach is centred on understanding the unmet legal needs of innovative life sciences businesses. He combines deep sector knowledge with practical commercial advice, helping clients manage legal risk while accelerating growth. His ambition is to leverage Browne Jacobson’s market-leading health and life sciences expertise, international reach and technology capabilities to deliver greater value to companies operating across the sector.
Over the past 15 years, Kevin has worked almost exclusively with innovative life sciences businesses, becoming a trusted adviser to many of Ireland’s leading indigenous companies. His sector focus gives him an in-depth understanding of the commercial challenges companies face from spin-out through to international scale-up.
His practice includes intellectual property licensing, manufacturing and supply, research collaborations, clinical research, distribution and strategic commercial transactions. He works closely with founders, management teams and investors to deliver practical, commercially focused advice that supports growth.
As part of Browne Jacobson’s internationally recognised health and life sciences team, Kevin advises companies throughout their lifecycle and supports their expansion into the UK and international markets. A significant part of his role focuses on deploying legal technology and developing AI-enabled legal solutions that improve how life sciences companies access specialist legal advice.
Kevin also serves as Board Member of Galway Hospice.
Kevin Reed is Business Development Manager at Invest Manchester – the inward investment promotion agency for Greater Manchester, UK. He provides specialist growth support to companies working within and across the Health Innovation and Life Sciences sector.
Invest Manchester’s role is simple but powerful: to attract new investment to the city region which helps to create and safeguard jobs.
The organisation tells Greater Manchester’s story to the world – championing the region’s strengths, opportunities and ambition – by providing free hands-on, practical support to businesses looking to relocate or expand. From global corporates to high-growth SMEs, Invest Manchester has helped hundreds of companies successfully establish and scale their presence in Greater Manchester.
With deep local knowledge, global reach and a strong network across the public and private sectors, we help businesses move with confidence and succeed faster.
Invest Manchester is wholly owned by the Greater Manchester Combined Authority, our majority funder and the strategic body responsible for driving economic growth across the city region.
Since 2017, our work has been further strengthened through the Invest Manchester Partnership – a public-private collaboration that brings together senior leaders from across Greater Manchester’s business community.
Invest Manchester also forms part of The Growth Company, which supports the growth and prosperity of Greater Manchester by raising the region’s profile, attracting investment, generating new business, supporting existing companies to grow, and helping people develop skills and access employment opportunities.
Claire Williams is Head of Pharmacovigilance and Regulatory Services at NorthWest EHealth and an expert in real-world safety monitoring. Having worked with NWEH since the landmark Salford Lung Studies, Claire has helped develop technology-enabled pharmacovigilance across large pragmatic clinical trials, using routinely collected healthcare and trial data to identify potential safety events earlier. She works closely with technical and clinical teams to develop innovative approaches that move safety monitoring from reactive reporting towards proactive, real-time surveillance. Claire holds an MSc in Pharmacovigilance, chairs the Greater Manchester Central Research Ethics Committee, and is a passionate advocate for inclusive research and women’s health.
Daniel Zamora is Programme Director at Health Innovation Manchester responsible for the delivery of large scale partnership triple-helix programmes in Greater Manchester and Innovator Support services. He has previously led NHS Business Support Programmes, part-funded by the European Regional Development Fund across Cheshire East and Greater Manchester, aimed at supporting Small and Medium Enterprises SMEs. Daniel worked for 25+ years in healthcare and spent his last 15 years in research an innovation positions within the NHS.
Daniel started his career with Alcon Laboratories working across marketing, sales, business development and customer services, leading teams to develop both the Pharmaceutical and Medical Device business units. Daniel moved to the UK in 2008 to study an MBA at Manchester Business School and since then has held several senior management positions supporting NHS and University organisations, such as North West e-Health, Trustech, Manchester University NHS Foundation Trust and currently Health Innovation Manchester. He is also committee member for the HIMSS UK and Ireland community.
Hannah began as Head of Fundraising for The Joshua Tree in 2026, as part of the charity’s mission to increase fundraising and support more families. She is building a coalition of businesses supporting families affected by childhood cancers across GM & the North West. Her background has seen her build charity fundraising partnerships with regional and national organisations, delivering real social impact.
Jenny Ostridge is Programme Manager for the Greater Manchester Wearables and Remote Monitoring Innovation Cluster (GM-WIC). She works across the NHS, academia and industry to build collaborations that accelerate the development and adoption of wearable and remote monitoring technologies. With a background in NHS innovation partnerships, Jenny focuses on connecting people, expertise and opportunities to help turn innovative ideas into real-world healthcare impact.
Head of Innovation – Bruntwood SciTech – Development of the life sciences, digital and technology ecosystem across the Bruntwood SciTech portfolio in the North West.
Applying my experiences gained from>20 years across pharmaceutical drug discovery and development. My mission is to drive the success of companies across the Bruntwood SciTech portfolio by ensuring the physical spaces, connections and events encourage growth, and reducing the barriers for start ups to take great ideas into action.
Matthew is a solicitor and Partner in Myerson’s Corporate and Commercial team, and serves as a sector lead for their Healthcare offering.
Matthew’s client base comprises a mixture of GPs, dentists, pharmacists, and care home operators. His experience includes advising on acquisitions and business disposals, corporate governance and structuring, regulatory matters specific to the sector and general compliance.
Matthew previously spent three years as in-house legal counsel in the healthcare sector, including two years leading the legal function of a national healthcare provider and consolidator from their Manchester office, where he worked in collaboration with the NHS – both at national and local commissioning levels – and the CQC to implement one of the earliest multi-site GP partnership structures.
Paul Lynch is Director of Strategy and Health Equity at NHS Greater Manchester Integrated Care Board, with a career focused on leading strategy development and implementation, system change, strategic commissioning, partnership development and public service reform.
He works across health, care and wider public sector organisations to drive collaborative approaches that improve outcomes for communities across Greater Manchester. Paul has led major programmes including neighbourhood health as part of Greater Manchester Live Well, prevention, integrated care, and system commissioning strategy.
Rebecca is a corporate commercial lawyer specialising in the health sector. Her clients include NHS organisations and other health and social care providers in the North West and nationally. Rebecca has been the operational lead lawyer on several major NHS transformation projects including mergers between NHS trusts / foundation trusts and the establishment of integrated care systems. Rebecca joined Browne Jacobson in 2019 and has previously worked in-house at NHS Improvement / Monitor, the Care Quality Commission and the Government Legal Department. Rebecca was named “Lawyer of the Year” at the Made in Manchester Awards 2023.
Shainoor (Shain) Khoja is a physiotherapist, social-impact entrepreneur and Founder & CEO of Thriving.ai. Drawing on more than 25 years working across health and social impact, alongside her own experience of caring for ageing family members, Shain is passionate about rethinking how we support people beyond traditional healthcare settings. Thriving.ai connects individuals, families, community organisations and care teams, using everyday health, wellbeing and home-based insights to support more proactive, personalised care. Her current focus is on how neighbourhood health can connect the signals, people and services around an individual to enable earlier support and healthier, more independent lives.
Sim leads the GMC Life Sciences Fund By PXN Ventures in partnership with Bruntwood SciTech, the Greater Manchester Combined Authority and Enterprise Cheshire + Warrington. The aim of the fund is to support life sciences businesses based in Greater Manchester and Cheshire or those who are committed to scaling here, with leading scale-ups such as SiSU Health, Silveray, CareLoop and Re:course AI making up the fund’s portfolio. With around two decades of experience in financial services across banking, funds and real estate, Sim works closely with founders and research institutions to back innovations with strong commercial potential. Sim’s leadership has helped establish PXN as a leading investor among the North’s life sciences ecosystem.
My group’s work is focused on the development and evaluation of imaging biomarkers for breast cancer risk prediction and early detection, and the science underpinning stratified screening. Our research encompasses a range of technologies both for breast density measurement and early detection of cancer. Recent projects include developing AI for risk prediction from standard and ultra-low-dose mammograms, evaluation of the impact of computer aided detection on reader behaviour and performance, reader variability studies, developing fair and explainable AI, predicting breast cancer subtypes, and the use of contrast enhanced mammography for evaluation of breast lesions. Our research is collaborative within a multidisciplinary network of scientists and clinicians in the UK and overseas.
Interested In The Event?
If you’re interested in attending, you can book online here.
For any further enquires about this event, contact [email protected]